每周股票复盘：硕世生物（688399）预计2025年净亏损2940万至4400万元

Core Viewpoint - Shuoshi Biotechnology (688399) is expected to report significant losses for the year 2025, with net profit projections indicating a loss between 29.4 million to 44 million yuan, reflecting a worsening financial situation compared to the previous year [1][3] Performance Disclosure Highlights - The company anticipates a net profit loss attributable to shareholders of 29.4 million to 44 million yuan for the year 2025 [1][3] - The projected net profit loss after excluding non-recurring gains and losses is expected to be between 81.9 million to 123 million yuan [1][3] Company Announcement Summary - The anticipated losses are attributed to several factors, including intensified industry competition, the advancement of centralized procurement in the medical sector, a reduction in government subsidies, and adjustments in the value-added tax rate for self-produced testing reagents [1][3]